BR0112644A - Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer - Google Patents

Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer

Info

Publication number
BR0112644A
BR0112644A BR0112644-0A BR0112644A BR0112644A BR 0112644 A BR0112644 A BR 0112644A BR 0112644 A BR0112644 A BR 0112644A BR 0112644 A BR0112644 A BR 0112644A
Authority
BR
Brazil
Prior art keywords
cancer
diagnosis
markers
identifying
cancer markers
Prior art date
Application number
BR0112644-0A
Other languages
English (en)
Inventor
Christopher Richard Parish
Vivian Mae Cabalda-Crane
Original Assignee
Biotron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotron Ltd filed Critical Biotron Ltd
Publication of BR0112644A publication Critical patent/BR0112644A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08—Sphingolipids
    • G01N2405/10—Glycosphingolipids, e.g. cerebrosides, gangliosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"MéTODO DE IDENTIFICAR MARCADORES DE CâNCER E USOS DESTES NO DIAGNóSTICO DO CâNCER". A presente invenção providencia um método baseado em espectrometria de massa para identificar um marcador de câncer no soro, e utilização do marcador de câncer no diagnóstico do câncer em indivíduo humanos e não-humanos. A invenção providencia ainda marcadores de câncer isolados.
BR0112644-0A 2000-07-19 2001-07-19 Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer BR0112644A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ8861A AUPQ886100A0 (en) 2000-07-19 2000-07-19 Diagnostic test
PCT/AU2001/000877 WO2002008760A1 (en) 2000-07-19 2001-07-19 Method of identifying cancer markers and uses therefor in the diagnosis of cancer

Publications (1)

Publication Number Publication Date
BR0112644A true BR0112644A (pt) 2003-06-24

Family

ID=3822924

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112644-0A BR0112644A (pt) 2000-07-19 2001-07-19 Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer

Country Status (11)

Country Link
US (1) US20040029194A1 (pt)
EP (1) EP1319178A4 (pt)
JP (1) JP2004504621A (pt)
KR (1) KR20030031126A (pt)
CN (1) CN1449496A (pt)
AU (1) AUPQ886100A0 (pt)
BR (1) BR0112644A (pt)
CA (1) CA2416375A1 (pt)
NZ (1) NZ524197A (pt)
WO (1) WO2002008760A1 (pt)
ZA (1) ZA200301211B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0211697A (pt) * 2001-08-03 2004-07-13 Biotron Ltd Marcador de câncer e usos deste na diagnose de câncer
CA2478036A1 (en) * 2002-03-06 2003-09-18 Johns Hopkins University Use of biomarkers to detect breast cancer
US20040229380A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB heterodimers as biomarkers
US20040229294A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
US7402397B2 (en) 2002-05-21 2008-07-22 Monogram Biosciences, Inc. Detecting and profiling molecular complexes
AU2002950878A0 (en) * 2002-08-20 2002-09-12 Proteome Systems Intellectual Property Pty Ltd Method for diagnosing disorders
DE10304106A1 (de) * 2003-01-31 2004-08-26 Mosaiques Diagnostics And Therapeutics Ag Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
US20040236603A1 (en) * 2003-05-22 2004-11-25 Biospect, Inc. System of analyzing complex mixtures of biological and other fluids to identify biological state information
US7425700B2 (en) * 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
EP1681983A4 (en) * 2003-10-14 2008-12-10 Monogram Biosciences Inc RECEPTOR TYROSINE KINASE SIGNAL PATH ANALYSIS FOR DIAGNOSIS AND THERAPY
US7707039B2 (en) * 2004-02-15 2010-04-27 Exbiblio B.V. Automatic modification of web pages
EP2221618A3 (en) * 2004-04-20 2010-09-01 Board Of Regents Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disase in hematologic malignancies
US20050244973A1 (en) * 2004-04-29 2005-11-03 Predicant Biosciences, Inc. Biological patterns for diagnosis and treatment of cancer
US7651847B2 (en) * 2004-06-22 2010-01-26 The Regents Of The University Of California Methods of oligosaccharide profiling for the detection of cancer
US7892752B2 (en) 2005-04-26 2011-02-22 Dwek Raymond A Glycosylation markers for cancer diagnosing and monitoring
WO2006114659A1 (en) 2005-04-26 2006-11-02 Dwek Raymond A Glycosylation markers for cancer diagnosing and monitoring
US8039208B2 (en) 2005-04-26 2011-10-18 National Institute For Bioprocessing Research And Training Limited (Nibrt) Automated strategy for identifying physiological glycosylation markers(s)
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
US7491504B2 (en) * 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
US7482161B2 (en) * 2006-07-17 2009-01-27 Bio-Rad Laboratories, Inc. Preparation of a red blood cell component for a hematology control
JP5212893B2 (ja) * 2008-05-09 2013-06-19 住友ベークライト株式会社 Ｎ結合型糖鎖を利用した膵臓癌の診断方法
US8941059B2 (en) * 2010-10-29 2015-01-27 Atonarp, Inc. Sampling apparatus
JP5977174B2 (ja) * 2010-12-13 2016-08-24 Ｊｃｒファーマ株式会社 スフィンゴ糖脂質の定量法
WO2012153964A2 (ko) * 2011-05-09 2012-11-15 국립암센터 지질 프로파일을 이용한 비소세포성 폐암의 조직학적 분류를 위한 정보를 제공하는 방법
KR101314097B1 (ko) 2011-05-11 2013-10-04 국립암센터 말디 질량분석 패턴으로 원발부위 불명 선암의 조직기원을 예측하는 방법
KR101648926B1 (ko) * 2015-09-03 2016-08-18 주식회사 아스타 생물학적 복합 유체 내의 n-글라이칸을 분석하는 방법
CN106950379B (zh) * 2017-03-02 2019-01-22 江苏先思达生物科技有限公司 一种肺癌监测试剂盒及其使用方法
CN109655449B (zh) * 2018-12-19 2021-10-01 杭州邦沃森生物科技有限公司 利用激光解吸附测定鱼肉中微囊藻毒素的方法
WO2021026172A1 (en) 2019-08-05 2021-02-11 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679636A (en) * 1992-03-30 1997-10-21 Board Of Regents, The University Of Texas Bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
WO1998000711A1 (en) * 1996-07-03 1998-01-08 Millenium Pharmaceuticals, Inc. Detection of cancer by assaying for cancer-specific antigens having linked oligosaccharides which are at least triantennary
JP2004500553A (ja) * 1999-10-07 2004-01-08 シファーゲン　バイオシステムズ，　インコーポレイテッド 前立腺ガンのマーカータンパク質
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer

Also Published As

Publication number Publication date
CN1449496A (zh) 2003-10-15
US20040029194A1 (en) 2004-02-12
EP1319178A1 (en) 2003-06-18
WO2002008760A8 (en) 2002-04-18
WO2002008760A1 (en) 2002-01-31
KR20030031126A (ko) 2003-04-18
CA2416375A1 (en) 2002-01-31
NZ524197A (en) 2004-09-24
JP2004504621A (ja) 2004-02-12
EP1319178A4 (en) 2004-05-06
ZA200301211B (en) 2004-02-04
AUPQ886100A0 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
BR0112644A (pt) Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
DE69932125D1 (de) Vorrichtung zur untersuchung von körperflüssigkeiten
ATE319855T1 (de) Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung
DE60212752D1 (de) Biopsieinstrument mit Element zur Markierung von Gewebe
DE69911125D1 (de) Vorrichtung zur Verabreichung von Narkosemitteln
CY1110256T1 (el) Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου
DK1303223T3 (da) Kranielapklemme og instrument til anvendelse sammen med denne
BR0009206A (pt) Isolamento e análise de proteina
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
DE602004019812D1 (de) Marker für neuromyelitis optica
BRPI0405883A (pt) Formulações contendo gingko para a melhora do brilho da pele
DE60127104D1 (de) Prostatakrebs-marker
BR0316324A (pt) Polipeptìdeos e conjugados de interferon-alfa
ATE350662T1 (de) Markerproteine für prostatakrebs
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
EP1451552A4 (en) FOR DETECTING DISORDERS OF BREAST SUITABLE REAGENTS AND METHODS
BR0211697A (pt) Marcador de câncer e usos deste na diagnose de câncer
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
BR0110206A (pt) Inibidores de peptìdeo deformilase
SE0200214D0 (sv) Vorrichtung zur Anzeige von Nutzerinformationen
BR0214287A (pt) limpador contendo um inibidor de urease para reduzir a produção de amÈnia proveniente da urina
DE10190171D2 (de) Vorrichtung zur daktyloskopischen Personenidentifikation
EP1323732A4 (en) BETA-CATENINE NUCLEAR LOCALIZING PROTEIN
DE60131665D1 (de) Vorrichtung zur mikrostromtherapie

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2021 DE 29/09/2009.